StemSight

Eyestem

The company develops cell replacement therapies to treat incurable blindness and retinal diseases for patients globally.

InGel Therapeutics

The company develops stem-cell therapies and biodegradable hydrogels for patients suffering from retinal degeneration and blinding diseases like retinitis pigmentosa.

EyeYon

This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.

Claris Bio

This biotechnology company develops topical therapies for patients with orphan ophthalmic disorders and corneal diseases including limbal stem cell deficiency.

Cirrus Therapeutics

This company develops gene and cell therapies to treat age-related macular degeneration and chronic vision loss for patients with blinding eye diseases.

CIRC Biosciences

This cell therapy company develops chemically induced retinal cells to restore vision for patients with macular degeneration and retinitis pigmentosa.

RhyGaze

This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.

GelMEDIX

GelMEDIX develops injectable hydrogel scaffolds and regenerative cell therapies to treat degenerative ocular diseases such as geographic atrophy for patients with vision loss.